Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Purified mammalian CTLA-8 antigens and related reagents

Purified mammalian CTLA-8 antigens and related reagents

US Patent 6274711 · Granted Aug 14, 2001

Estimated economic value: $275,809,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and apparatus for identifying alternative splicing events2024
Agents that engage antigen-presenting cells through dendritic cell asialoglycopr2024
Fusion proteins comprising an anti-CD40 antibody and cancer antigens2023
Breast cancer splice variants2023
Compositions and methods for the systemic treatment of arthritis2022
Nucleic acids encoding anti-CD40 antibodies2022
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides2021
Fusion proteins comprising an anti-CD40 antibody and cancer antigens2021
Compositions and methods for the systemic treatment of arthritis2020
Anti-CD40 antibodies2020
Method of making an anti-CD40 antibody2018
Methods and compositions for treating breast cancer with dendritic cell vaccines2018